Canada markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4700+0.0600 (+4.26%)
At close: 04:00PM EDT
1.4700 0.00 (0.00%)
After hours: 07:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 184.23M
Enterprise Value 100.27M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.15
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 2.01

Trading Information

Stock Price History

Beta (5Y Monthly) 1.21
52-Week Change 333.64%
S&P500 52-Week Change 318.96%
52 Week High 32.3100
52 Week Low 30.6200
50-Day Moving Average 31.3054
200-Day Moving Average 31.1207

Share Statistics

Avg Vol (3 month) 31.31M
Avg Vol (10 day) 3989.64k
Shares Outstanding 5125.76M
Implied Shares Outstanding 6125.76M
Float 8117.92M
% Held by Insiders 10.06%
% Held by Institutions 121.73%
Shares Short (Jul 15, 2024) 412.34M
Short Ratio (Jul 15, 2024) 46.53
Short % of Float (Jul 15, 2024) 49.81%
Short % of Shares Outstanding (Jul 15, 2024) 49.81%
Shares Short (prior month Jun 14, 2024) 410.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 20, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Apr 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-18.85%
Return on Equity (ttm)-29.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.23M
Net Income Avi to Common (ttm)-29.69M
Diluted EPS (ttm)-0.2400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)83.96M
Total Cash Per Share (mrq)0.67
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)16.34
Book Value Per Share (mrq)0.68

Cash Flow Statement

Operating Cash Flow (ttm)-18.62M
Levered Free Cash Flow (ttm)-9.78M